White papers | Addiction Professional Magazine Skip to content Skip to navigation

White papers

  • Info: Understanding Addiction and Mental Health Issues

    The behavioral healthcare field is still hard at work on educating the world that addiction, much like all mental health disorders, is a disease and should be treated as such. In turn, those who suffer from addiction deserve the same treatment opportunities afforded to those with physical injury, internal illnesses, and other issues that may handicap a person’s everyday activities.

  • Info: History of the Opioid Epidemic

    “Those who cannot remember the past are condemned to repeat it.” As we fight to quell the opioid epidemic, philosopher George Santayana’s words ring true. This epidemic has plagued the United States from as early as the Civil War, and we are still combating opioid addiction, overdoses and overprescribing.

  • FRN Mental Health Outcomes

    According to a 2013 Substance Abuse and Mental Health Services Administration (SAMHSA) survey, of the 43.8 million adults with a mental illness and the 20.3 million with substance use disorders (SUD), 7.7 million adults suffered from both. Foundations Recovery Network (FRN) sought to find optimal methods of dual diagnosis treatment for their patients.

  • FRN Research and Outcomes One Year Post-Treatment

    Many addiction treatment programs determine their successes based on what occurs at the time of treatment. However, Foundations Recovery Network (FRN) notes that a fairer measure of success should be patient’s condition and quality of life months after initially receiving treatment.

  • Helping Patients Remain in Treatment Supports Positive Long-Term Outcomes


    Study: Identifying Risk Factors to Alleviate ACA Discharge and Improve Patient Outcomes

    Early identification allows for early intervention. Early intervention leads to improved outcomes.

    Recognizing patients who could be at risk is an important step in the treatment process. By understanding which patients are at risk of leaving against clinical advice (ACA) and what to look for during intake—clinical teams can proactively prevent ACA discharge and ultimately positively impact long-term outcomes for patients and their families.

  • Landscape of Clinical Evidence for Pharmacogenetic Testing (PGT): Summary of Current Evidence and Expert Perspectives


    Genetic testing can determine how a patient will respond to specific medications based on their genetic makeup. It can produce information on medication response, providing crucial data to clinicians in key moments during treatment, and addressing the age-old question of why certain medications work, and others do not.

    In this white paper, explore the latest research and processes surrounding genetic testing protocols during treatment, and learn how to:

  • Alcohol Deterrence Tactics : Current Testing Trends and Emerging Technology to Support Sobriety

    Orasure Technologies

    The impact of alcohol consumption on criminal justice facilities has been well documented. Departments would like to test individuals in their programs more frequently to facilitate effective prevention and sobriety assurance programs, but in the past have not had a low-cost, self-administered test available. With the new technologies in testing such as near-infrared spectroscopy, frequent alcohol screening will play a significant role in creating true alcohol deterrence solutions.

    Download this white paper to learn more about new technology and testing solutions.

  • Women, Addiction, and Mental Health: The Vulnerable Population

    Union Institute & University

    The need to consider treatment issues and characteristics of women as a select population in treatment has become critical, as both research and clinical evidence have identified gender-specific risk factors, accelerated progression, and comorbidities particular to women. The white paper from Union Institute & University's Associate Dean of Graduate Psychology, Dr.

  • The Power of Relationships in Recovery

    OraSure Technologies, Inc.

    During the past three decades we have achieved a greater understanding of addiction as a chronic brain disease.  We now approach the treatment of addiction as we would any other acute illness, like diabetes or heart disease. And while we have lots of different pharmacological, psychotherapeutic and psychoeducational approaches in our treatment repertoire, there is one aspect of addiction treatment that we may have overlooked: the power of relationships.